Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,192 | 184,201 | 112,724 | 96,648 | 175,787 |
| Marketable Securities | 286,540 | 233,627 | 289,113 | 284,495 | 232,129 |
| Receivables | 117,207 | 87,109 | 74,336 | 60,240 | 64,153 |
| Inventories | 4,572 | 4,372 | 3,836 | 3,873 | 2,705 |
| TOTAL | $537,229 | $522,782 | $501,704 | $474,429 | $480,773 |
| Non-Current Assets | |||||
| PPE Net | 17,672 | 11,665 | 5,746 | 3,182 | 2,787 |
| Investments And Advances | 3,870 | 3,870 | 3,000 | 3,000 | 3,000 |
| Intangibles | 7,126 | 7,366 | 7,606 | 7,846 | 8,086 |
| Other Non-Current Assets | 15,238 | 16,475 | 16,505 | 6,537 | 6,104 |
| TOTAL | $43,906 | $39,376 | $32,857 | $20,565 | $19,977 |
| Total Assets | $581,135 | $562,158 | $534,561 | $494,994 | $500,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,131 | 16,387 | 103,498 | 78,641 | 76,375 |
| TOTAL | $143,508 | $135,695 | $117,050 | $90,253 | $86,308 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,597 | 72,438 | 72,281 | 72,129 | 71,984 |
| Other Non-Current Liabilities | 16,079 | 10,599 | 10,148 | 0 | 0 |
| TOTAL | $88,676 | $83,037 | $82,429 | $72,129 | $71,984 |
| Total Liabilities | $232,184 | $218,732 | $199,479 | $162,382 | $158,292 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,024 | 42,557 | 42,449 | 42,214 | 42,014 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -433,595 | -426,628 | -418,255 | -405,670 | -385,330 |
| Other shareholders' equity | -298 | 381 | 289 | 39 | 85 |
| TOTAL | $348,951 | $343,426 | $335,082 | $332,612 | $342,458 |
| Total Liabilities And Equity | $581,135 | $562,158 | $534,561 | $494,994 | $500,750 |